Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Commentary · 1 Jul 2026 Perspective · 31 Dec 2025 Splicing Defects and Therapeutic Restoration in Spinal Muscular Atrophy
Article · 30 Sep 2024 Pathophysiology and Genetics of Hereditary Spinal Muscular Atrophy in Canines
Short communication · 2 Jul 2024 Antisense Oligonucleotides Therapy: An Appropriate Approach for Spinal Muscular Atrophy Genetic Management
Mini review · 24 May 2024 Advancements in the Treatment of Pediatric Spinal Muscular Atrophy
Perspective · 24 Jan 2024 Navigating life with spinal muscular atrophy: Diagnosis, care, and emerging therapies
Short communication · 27 Dec 2023 Cracking the code of spinal muscular atrophy progress, challenges, and hope
Commentary · 31 Oct 2022 Spinal Muscular Atrophy Inherited Disorder that Impacts Nerves and Muscles
Opinion · 18 Apr 2022 A Short Note on Spinal Muscular Atrophy
Opinion · 29 Mar 2022 What is SMA (spinal muscular atrophy) in children?
Editorial · 28 Mar 2022 To Assess Economic Evaluations in Spinal Muscular Atrophy (SMA)
Perspective · 28 Mar 2022 To Assess the Cost and Resource Use Associated with Spinal Muscular Atrophy Management
Short communication · 28 Sep 2021 A Note on Molecular Pathogenesis of Spinal Muscular Atrophy
Conference proceeding · 2020 NUSINERSEN, NEWER DRUG FOR SPINAL MUSCULAR ATROPHY
Conference abstract · 1 Apr 2019 Discovery of risdiplam, a selective survival of motor neuron-2 (SMN2) gene splicing modifier for the treatment of spinal muscular atrophy (SMA)
SMA is an inherited disease that leads to loss of motor function
Conference abstract · 13 Aug 2012 Molecular diagnosis and therapeutic studies of spinal muscular atrophy (SMA) and duchenne muscular dystrophy (DMD); Challenges and opportunities in Malaysia
S ingle-gene neuromuscular disorders, such as SMA and DMD, are among
Conference abstract · 5 Aug 2013 Regulation of motor neuron degeneration in spinal muscular atrophy-A new pathogenic mechanism and treatment strategy
Spinal muscular atrophy (SMA), the leading genetic cause of infant mortality, is characterized by the loss of spinal motor neurons controlling locomotion. However, the pathogenic mechanism of SMA remains largely
Research article · 2 May 2017 CONTRAST DYNAMIC MR IMAGING IN HIRAYAMA DISEASE ON A 3-TESLA MRI SCANNER IN A TERTIARY CARE CENTRE IN EASTERN INDIA
Hirayama disease, also termed non-progressive juvenile spinal muscular atrophy of the distal upper limbs, is a type of cervical myelopathy related to flexion movements of the neck. The objective
Case report · 27 Feb 2023 A Case of Spinal and Bulbar Muscular Atrophy Requiring Amputation and Airway Support
Spinal and bulbar muscular atrophy (SBMA) is a rare neuromuscular disorder. Here, we present the case of a 53-year-old male diagnosed with SBMA, who underwent left leg amputation
Editorial · 29 Apr 2025 Global Newborn Screening: Genomics, Equity, Ethical Future
This collection of articles explores the evolving landscape of newborn screening, addressing
Perspective · 1 Dec 2025 Pediatric Neuromuscular Disorders: Advances, Challenges, and Hope
This review synthesizes current knowledge on pediatric neuromuscular disorders, highlighting advances in
Short communication · 3 Sep 2023 Advancements in Pediatric Healthcare

